Diclofenac epolamine
Diclofenac epolamine is a nonsteroidal anti-inflammatory drug (NSAID) formulated as an epolamine salt to enhance absorption through the skin. It provides targeted, localized relief from pain and inflammation while minimizing systemic side effects compared to oral NSAIDs.
Dosage by Body Weight
For topical patches (e.g., Flector), apply one patch to the most painful area twice daily (every 12 hours). Do not apply to damaged or non-intact skin. Avoid contact with eyes and mucosal membranes. Pediatric dosing is not established.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness in pediatric patients under 18 years of age have not been established.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness in pediatric patients under 18 years of age have not been established.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness in pediatric patients under 18 years of age have not been established.
- Body Weight
- 11-15 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness in pediatric patients under 18 years of age have not been established.
- Body Weight
- 16-20 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness in pediatric patients under 18 years of age have not been established.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | N/A | Safety and effectiveness in pediatric patients under 18 years of age have not been established. |
| 5-7 kg | Not recommended | N/A | Safety and effectiveness in pediatric patients under 18 years of age have not been established. |
| 8-10 kg | Not recommended | N/A | Safety and effectiveness in pediatric patients under 18 years of age have not been established. |
| 11-15 kg | Not recommended | N/A | Safety and effectiveness in pediatric patients under 18 years of age have not been established. |
| 16-20 kg | Not recommended | N/A | Safety and effectiveness in pediatric patients under 18 years of age have not been established. |
Formulation
Purpose
Used for the acute treatment of localized pain due to minor strains, sprains, contusions, and osteoarthritis joint pain.
Generic Name
Diclofenac epolamineBranded Drug Names
Diclofenac epolamine is listed as a generic drug name. Common branded medicines that may contain the same active ingredient include:
Scheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.